Skip to main content
. 2020 Nov 19;20:555. doi: 10.1186/s12935-020-01635-8

Fig. 6.

Fig. 6

Kaplan–Meier analyses of OS according to the prognostic model risk score classifier in subgroups of NSCLC (HBV+) patients in the training cohort (left) and the validation cohort (right): (a) total patients; (b) stage I/II; (c) stage III/IV